Clinical diagnosis definition

Clinical diagnosis means the observation by a licensed
Sample 1Sample 2Sample 3
Clinical diagnosis means a process in which a sample of fluid or other material collected from individual humans that is used to aid in diagnosis of one or more human diseases, the results of such process used for communication to such persons or their physicians or other caregivers for clinical decisions in connection with such individual humans.
Sample 1Sample 2
Clinical diagnosis means a diagnosis that is based on knowledge obtained through medical history and physical examination alone or in conjunction with testing that provides supportive data for the diagnosis.
Sample 1

Examples of Clinical diagnosis in a sentence

  • Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease.

  • Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

  • Clinical diagnosis of depression in primary care: a meta-analysis.

  • This separation of the roles of Chairman and Chief Executive Officer allows for greater oversight of the Company by the Board.

  • Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan.

  • Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

  • Clinical diagnosis and management of tuberculosis, and measures for its prevention and control.

  • Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Dis- ease.

  • Clinical diagnosis of sleep apnea based on single night of polysomnography vs.


More Definitions of Clinical diagnosis

Clinical diagnosis means a clinical identification of cancer based on history, laboratory study and symptoms. We will pay benefits for a clinical diagnosis only if:
Sample 1
Clinical diagnosis. A diagnosis of Cancer based upon symptoms and diagnostic test results. We will regard as valid a Clinical Diagnosis of Cancer if and only if the following conditions are met: • Pathological Diagnosis cannot be made because: • it is medically inappropriate or carries the potential for severe harm to the Covered Person; and • medical evidence exists to support the diagnosis; and • A Physician is treating the Covered Person for Cancer. Covered Person: A person listed on the Schedule as insured under this Policy. SAMPLE Cancer: Cancer is limited to the following: Carcinoma in Situ: A Cancer that is in the natural or normal location and is restricted to the site of origin without invasion of neighboring tissues. Diagnosis of Carcinoma in Situ shall be based on Clinical Diagnosis, Pathological Diagnosis, or any type of appropriate diagnosis. Benefits for Carcinoma in Situ are limited to the Partial Benefit Amount specified in the Schedule of Benefits. Cancers such as the following are not considered Carcinoma in Situ: • Basal cell carcinoma and squamous cell carcinoma of the skin; or • Melanoma that is diagnosed as Xxxxx’x level I or level II or Xxxxxxx’x classification less than 0.75mm; • Premalignant tumors or polyps. The date of diagnosis is the date on which the tissue specimen, blood sample, and/or titer, which form/s the basis for the diagnosis of Carcinoma in Situ, is/are taken. In the event that such studies do not provide the basis for the diagnosis, the date of diagnosis is the date a clinical or other appropriate diagnosis is made, based on generally accepted principles of medicine in the United States at the time the diagnosis is made.
Sample 1
Clinical diagnosis means the acts of performing clinical diagnostic analysis of a Patient Report and providing medical advice and services to the Patient (directly or indirectly).
Sample 1
Clinical diagnosis means a process in which a sample of fluid or other material collected from humans is used to aid in diagnosis of one or more human diseases for communication to such persons or their physicians or other caregivers for clinical decisions and other clinical uses in connection with such humans. 1.8 "Collaboration" means the research and development program jointly conceived, planned, organized, controlled and performed by AFFX and BMX pursuant to this Agreement. 1.9 "Collaboration Technology" means the Patents, Know-how and Copyrights developed by the Parties pursuant to the Collaboration. Such technology shall include and be limited to all technology developed by AFFX pursuant to Agreed Workplans or otherwise with funding from BMX hereunder and all technology developed by BMX relating to the adaptation of AFFX Licensed Core Technology for use in BMX diagnostic instrumentation and systems as the same exist or may be developed. Such technology does not include the AFFX Licensed Core Technology as it exists or may be developed outside of the Collaboration, and does not include the BMX instrumentation and system as it exists or may be developed, nor the BMX patents and applications referred to in Section 12.2(c). 1.10 "Confidential Information" means all information and materials, patentable or otherwise, of a Party which is disclosed by or on behalf of such Party to the other Party, including, but not limited to, DNA sequences, vectors, cells substances, formulations, techniques, methodology, equipment, data, reports, know-how, preclinical and clinical trials and the results thereof, sources of supply, patent positioning and business
Sample 1
Clinical diagnosis means a diagnosis based on the patient's history, physical and x ray examination and/or other laboratory examination but one that does not include microscopic or histological confirmation. Waiting Period A waiting period of ninety (90) days will apply from the effective date of this policy before coverage will become operative.
Sample 1
Clinical diagnosis means the observation by a licensed physician of signs and symptoms compatible with acute, persistent, or
Sample 1

Related to Clinical diagnosis

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Biological diversity means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Diagnosis means the definition of the nature of the Client's disorder. When formulating the Diagnosis of Client, CONTRACTOR shall use the diagnostic codes and axes as specified in the most current edition of the DSM published by the American Psychiatric Association. DSM diagnoses will be recorded on all IRIS documents, as appropriate.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Clinical Director means an individual who meets the minimum requirements set forth in Title 9, CCR, and has at least two (2) years of full-time professional experience working in a mental health setting.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.